Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDJade Biosciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$6.03 | -$6.03 | -$6.03 |
| Q2 2025 | 4 | -$0.65 | -$0.29 | -$0.43 |
| Q3 2025 | 4 | -$0.85 | -$0.53 | -$0.67 |
| Q4 2025 | 4 | -$0.70 | -$0.33 | -$0.49 |
| Q1 2026 | 2 | -$0.48 | -$0.48 | -$0.48 |
| Q2 2026 | 1 | -$0.50 | -$0.50 | -$0.50 |
| Q3 2026 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q4 2026 | 1 | -$0.61 | -$0.61 | -$0.61 |
Jade Biosciences, Inc. Earnings Date And Information
Jade Biosciences, Inc. last posted its earnings results on Thursday, November 13th, 2025. The company reported $-0.48 earnings per share for the quarter, topping analysts' consensus estimates of $-0.57 by $0.09. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Jade Biosciences, Inc. has generated $-85 earnings per share over the last year ($-85.2621 diluted earnings per share) and currently has a price-to-earnings ratio of -7.52. Jade Biosciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 14th, 2025 based on prior year's report dates.
Jade Biosciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/29/2025 | Q3 2025 | N/A | -$0.64 | N/A | $0 | $0 |
| 06/30/2025 | Q2 2025 | N/A | -$1.13 | N/A | $0 | $0 |
| 03/30/2025 | Q1 2025 | N/A | -$3.04 | N/A | $0 | $0 |
| 12/30/2024 | Q4 2024 | N/A | -$6.56 | N/A | N/A | $0 |
| 09/30/2024 | Q3 2024 | N/A | -$5.16 | N/A | N/A | $0 |
| 06/29/2024 | Q2 2024 | N/A | -$30.15 | N/A | N/A | $0 |
| 03/30/2024 | Q1 2024 | N/A | -$29.20 | N/A | N/A | $0 |
| 12/30/2023 | Q4 2023 | N/A | -$25.80 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$24.77 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Jade Biosciences, Inc. Earnings: FAQ's
Jade Biosciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 14th, 2025 based offlast year's report dates.
In the previous quarter, Jade Biosciences, Inc. (:JBIO) reported $-0.48 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.57 by $0.09.
The conference call for Jade Biosciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Jade Biosciences, Inc.'s latest earnings report can be read online.
Jade Biosciences, Inc. (:JBIO) has a recorded net income of $-69,628,000.Jade Biosciences, Inc. has generated $-85.2621 earnings per share over the last four quarters.
Jade Biosciences, Inc. (:JBIO) has a price-to-earnings ratio of -7.52 and price/earnings-to-growth ratio is -0.12.